In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The views of other organizations will appear in the next issue of Chain Drug Review We are, without a doubt, at a tipping point with the current state of pharmacy practice. Drug shortages, staffing shortages,
Change is inevitable. This is a particularly exciting time to be in pharmacy, as we witnessed pharmacists’ swift support on the front lines of the COVID-19 pandemic, further demonstrating the need for and value of pharmacist-provided patient care services, pharmacists’ value to their communities, and a future for the expanded role of pharmacists. The pharmacy
Through value-based arrangements (VBAs) and speed to standards development, NCPDP is taking bold steps to help power a new health care paradigm focused on improving patient health outcomes and reducing costs. It’s a paradigm that changes the dynamics between payors, providers and patients. It changes the way health care services are coordinated, managed, delivered and
The chaos and uncertainty of the pandemic, a polarizing political climate and continued civil unrest have challenged us — as individuals and organizations — and given us the opportunity to learn, grow and even redefine who we strive to be in our new normal. These are the times when we cling even closer to our
This year kicks off major events and activities for National Council for Prescription Drug Programs that will fortify our ability to effect change at a more rapid pace and scale in the near future. We took a step back in 2019 to assess where we are as an organization, where the industry is heading, and
